期刊文献+

成人原位肝移植术后糖尿病发生的危险因素分析

An analysis of risk factors for the development of diabetes mellitus after orthotopic liver transplantation in adults
下载PDF
导出
摘要 目的探讨成人原位肝移植术后糖尿病(post-transplant diabetes mellitus,PTDM)发生的危险因素。方法选择2017年7月1日—2023年1月31日我院原位肝移植手术患者293例,根据术后是否发生糖尿病分为PTDM组(66例)和非PTDM组(227例),收集两组患者的临床资料,对有差异的指标行多因素logistic回归分析成人PTDM发生的独立危险因素。绘制两组患者的Kaplan-Meier生存曲线,分析PTDM发生对患者生存率的影响。结果患者PTDM的发生率为22.5%。两组患者的年龄、术前空腹血糖水平、术前血清总胆固醇水平、术前血清低密度脂蛋白水平、术后应用环孢素患者构成比、术后应用抗免疫排斥方案C(单用环孢素/环孢素联合麦考酚酯或西罗莫司)或D(单用麦考酚酯或西罗莫司)患者构成比、高血压史患者构成比差异显著(t=-3.191,U=-5.668~-2.559,χ^(2)=3.922~5.689,P<0.05)。多因素logistic回归分析显示,年龄>46岁、高血压史、术前空腹血糖>6.1 mmol/L、术前血清低密度脂蛋白水平>3.12 mmol/L、术后应用抗免疫排斥方案C(单用环孢素/环孢素联合麦考酚酯或西罗莫司)是PTDM发生的独立危险因素。生存曲线分析结果显示,PTDM发生可降低患者的5年生存率(P<0.05)。结论年龄>46岁、高血压史、术前空腹血糖>6.1 mmol/L、术前血清低密度脂蛋白水平>3.12 mmol/L、术后单用环孢素/环孢素联合麦考酚酯或西罗莫司的抗免疫排斥方案是成人PTDM发生的独立危险因素。 Objective To investigate risk factors for the development of post-transplant diabetes mellitus(PTDM)in patients undergoing orthotopic liver transplantation.Methods We included 293 patients who underwent orthotopic liver transplantation at The Affiliated Hospital of Qingdao University from July 1,2017 to January 31,2023.According to whether PTDM occurred,the patients were divided into PTDM group(n=66)and non-PTDM group(n=227).Significantly different clinical para-meters between the two groups were included in a multivariable logistic regression model to determine independent risk factors for PTDM.The impact of PTDM on the survival rate of the patients was analyzed using a Kaplan-Meier survival curve.Results The incidence rate of PTDM among the patients was 22.5%.The PTDM group and non-PTDM group differed significantly in age,the percentage of patients with a history of hypertension,preoperative fasting blood glucose level,preoperative serum total cholesterol level,preoperative serum low-density lipoprotein level,the percentage of patients treated with cyclosporine after surgery,and the percentage of patients treated with anti-rejection regimen C(cyclosporine alone or combined with mycophenolate or sirolimus)or D(mycophenolate or sirolimus alone)after surgery(t=-3.191,U=-5.668--2.559,χ^(2)=3.922-5.689,P<0.05).The multivariable logistic regression analysis showed that age>46 years,a history of hypertension,preoperative fasting blood glucose level>6.1 mmol/L,preoperative serum low-density lipoprotein level>3.12 mmol/L,postoperative use of anti-rejection regimen C(cyclosporine alone or combined with mycophenolate or sirolimus)were independent risk factors for the occurrence of PTDM(P<0.05).The survival curve showed that the occurrence of PTDM significantly decreased the 5-year survival rate of the patients(P<0.05).Conclusion Age>46 years,a history of hypertension,preoperative fasting blood glucose level>6.1 mmol/L,preoperative serum low-density lipoprotein level>3.12 mmol/L,and postoperative anti-rejection treatment with cyclosporine alone or combined with mycophenolate or sirolimus are independent risk factors for adult PTDM.
作者 尚莹 邵非 孔心涓 SHANG Ying;SHAO Fei;KONG Xinjuan(Department of Gastroenterology,The Affiliated Hospital of Qingdao University,Qingdao 266003,China)
出处 《精准医学杂志》 2024年第4期341-345,351,共6页 Journal of Precision Medicine
关键词 肝移植 手术后并发症 糖尿病 危险因素 Liver transplantation Postoperative complications Diabetes mellitus Risk factors
  • 相关文献

参考文献6

二级参考文献65

  • 1Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post - transplant diabetes. KidneyInt,2002,62 (4) :1440 - 1446.
  • 2Greenspan LC, Gitelman SE, Leung MA, et al. Increased inci- dence in post - transplant diabetes mellitus in children : a case - control analysis. Pediatr Nephro1,2002,17 ( 1 ) : 1 - 5.
  • 3Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of ear- ly- diagnosed new -onset post- tansplantation diabetes melli- tus on survival and major cardiac events. Kidney Int, 2006,69 (3) :588 -595.
  • 4Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treat- ment and management of new - onset diabetes after transplanta- tion. Clin Transplant,2005,19 (3) : 291 - 298.
  • 5Gonzalez - Posada JM, Herndndez D, Genis BB, et al. Increased cardiovascular risk profile and mortality in kidney allograft recipi- ents with post - transplant diabetes mellitus in Spain. Clin Trans- plant, 2006,20 (5) : 650 - 658.
  • 6Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C,Duvoux C, Dumortier J, Salamé E, Calmus Y, Maugendre D. Riskfactors for new-onset diabetes mellitus following liver transplantationand impact of hepatitis C infection: an observational multicenterstudy. Liver Transpl 2007; 13: 136-144 [PMID: 17192854 DOI:10.1002/lt.21010].
  • 7Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, VargasHE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA.Pretransplant fasting glucose predicts new-onset diabetes after livertransplantation. J Transplant 2012; 2012: 614781 [PMID: 22461975DOI: 10.1155/2012/614781].
  • 8Honda M, Asonuma K, Hayashida S, Suda H, Ohya Y, Lee KJ,Yamamoto H, Takeichi T, Inomata Y. Incidence and risk factors fornew-onset diabetes in living-donor liver transplant recipients. ClinTransplant 2013; 27: 426-435 [PMID: 23464510 DOI: 10.1111/ctr.12103].
  • 9Kuo HT, Sampaio MS, Ye X, Reddy P, Martin P, BunnapradistS. Risk factors for new-onset diabetes mellitus in adult livertransplant recipients, an analysis of the Organ Procurement andTransplant Network/United Network for Organ Sharing database.Transplantation 2010; 89: 1134-1140 [PMID: 20386364 DOI:10.1097/TP.0b013e3181d2fec1].
  • 10Mirabella S, Brunati A, Ricchiuti A, Pierini A, Franchello A,Salizzoni M. New-onset diabetes after liver transplantation.Transplant Proc 2005; 37: 2636-2637 [PMID: 16182771 DOI:10.1016/j.transproceed.2005.06.084].

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部